Application 207563

Type
ANDA
Sponsor
INGENUS PHARMS LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DOCETAXELDOCETAXELINJECTABLE;INJECTION20MG/2ML (10MG/ML)NoNo
002DOCETAXELDOCETAXELINJECTABLE;INJECTION80MG/8ML (10MG/ML)NoNo
003DOCETAXELDOCETAXELINJECTABLE;INJECTION160MG/16ML (10MG/ML)NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50742-428DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-428DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-428DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-428DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-431DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-431DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-431DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-431DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-431DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-431DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-463DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-463DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-463DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-463DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-463DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent
50742-463DOCETAXELDOCETAXEL ANHYDROUSIngenus Pharmaceuticals, LLCANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
49686ORIG2017-09-07